Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

Naman Bansal June 19, 2025 PR

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

Bakingo Introduces a Fresh Take on Father’s Day with Its ‘Papa Update Ho Rahe Hain’ Campaign

This year’s Father’s Day collection is thoughtfully designed to make the celebration feel more personal, …